ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 197 filers reported holding ANI PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $603,824 | +7.9% | 10,400 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $559,832 | +45.8% | 10,400 | -12.6% | 0.00% | – |
| Q2 2020 | $384,000 | -72.8% | 11,897 | -65.7% | 0.00% | -100.0% |
| Q1 2020 | $1,412,000 | -9.5% | 34,653 | +37.0% | 0.00% | +100.0% |
| Q4 2019 | $1,560,000 | -13.9% | 25,298 | +1.8% | 0.00% | -50.0% |
| Q3 2019 | $1,812,000 | -64.7% | 24,862 | -60.2% | 0.00% | -60.0% |
| Q2 2019 | $5,131,000 | +15.3% | 62,417 | -1.1% | 0.01% | +25.0% |
| Q1 2019 | $4,451,000 | +54.3% | 63,098 | -1.5% | 0.00% | +33.3% |
| Q4 2018 | $2,885,000 | -24.1% | 64,084 | -4.6% | 0.00% | 0.0% |
| Q3 2018 | $3,800,000 | -31.0% | 67,204 | -18.5% | 0.00% | -40.0% |
| Q2 2018 | $5,511,000 | +12.6% | 82,505 | -1.9% | 0.01% | 0.0% |
| Q1 2018 | $4,895,000 | -18.8% | 84,071 | -10.1% | 0.01% | 0.0% |
| Q4 2017 | $6,028,000 | -5.9% | 93,531 | -23.3% | 0.01% | -16.7% |
| Q3 2017 | $6,404,000 | -7.1% | 121,994 | -17.4% | 0.01% | -14.3% |
| Q2 2017 | $6,894,000 | -11.8% | 147,738 | -6.5% | 0.01% | -12.5% |
| Q1 2017 | $7,820,000 | -27.6% | 157,944 | -11.4% | 0.01% | -20.0% |
| Q4 2016 | $10,804,000 | -1.9% | 178,225 | +7.3% | 0.01% | -9.1% |
| Q3 2016 | $11,015,000 | -0.3% | 166,023 | -16.1% | 0.01% | -8.3% |
| Q2 2016 | $11,046,000 | +76.7% | 197,890 | +6.5% | 0.01% | +71.4% |
| Q1 2016 | $6,252,000 | -24.2% | 185,739 | +1.6% | 0.01% | -22.2% |
| Q4 2015 | $8,250,000 | -3.4% | 182,829 | -15.4% | 0.01% | -10.0% |
| Q3 2015 | $8,540,000 | -35.6% | 216,141 | +1.2% | 0.01% | -28.6% |
| Q2 2015 | $13,252,000 | -2.2% | 213,562 | -1.5% | 0.01% | -6.7% |
| Q1 2015 | $13,556,000 | +6.5% | 216,724 | -4.0% | 0.02% | +7.1% |
| Q4 2014 | $12,732,000 | +14046.7% | 225,793 | +6956.0% | 0.01% | – |
| Q3 2014 | $90,000 | -18.2% | 3,200 | 0.0% | 0.00% | – |
| Q2 2014 | $110,000 | +10.0% | 3,200 | 0.0% | 0.00% | – |
| Q1 2014 | $100,000 | – | 3,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |